Christopher Mason has swabbed the NYC subway system before with surprising results. Now, with help from Twist Bioscience’s DNA chips, Chris is sampling the public transit system to see if and where the novel coronavirus is residing. Chris will be in conversation with Twist CEO Emily Leproust, as well as Josh Perfetto, founder and CEO of Chai Bio, which makes tools like Open qPCR accessible to researchers everywhere. We will discuss the process for public swabbing, and Josh will share results coming out in pre-print in the coming days.
top of page
bottom of page
コメント